Minerva Neurosciences Inc. sell StockNews.com
Summary
This prediction is currently active. The prediction for Minerva Neurosciences Inc. shows a convincing performance of -22.93%. This prediction currently runs until 19.06.25. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionMinerva Neurosciences (NASDAQ: NERV) is a clinical-stage biopharmaceutical company focused on developing innovative therapies for patients suffering from neuropsychiatric disorders. With a primary emphasis on central nervous system diseases such as schizophrenia, major depressive disorder, insomnia, and Parkinson's, Minerva Neurosciences is committed to addressing unmet medical needs and advancing the understanding of the underlying biology of these conditions. Utilizing a strong research and development platform, the company aims to create a diversified portfolio of novel therapies that have the potential to significantly improve patients' quality of life and help them lead more fulfilling lives.
Performance without dividends (%)
Name | 1w | 1m |
---|---|---|
Minerva Neurosciences Inc. | 5.085% | 5.085% |
iShares Core DAX® | 2.147% | 2.681% |
iShares Nasdaq 100 | -0.578% | -0.816% |
iShares Nikkei 225® | 0.635% | 3.079% |
iShares S&P 500 | 0.746% | 0.171% |
Comments by StockNews_com for this prediction
In the thread Minerva Neurosciences Inc. diskutieren
Stopped prediction by StockNews_com for Minerva Neurosciences Inc.
Minerva Neurosciences Inc.
21.07.24
21.07.25
27.08.24
Minerva Neurosciences Inc.
14.07.24
14.07.25
27.08.24
Minerva Neurosciences Inc.
05.07.24
05.07.25
27.08.24
Minerva Neurosciences Inc.
26.05.24
26.05.25
27.08.24
Minerva Neurosciences Inc.
18.05.24
18.05.25
27.08.24
Minerva Neurosciences Inc.
24.02.24
24.02.25
27.08.24
Minerva Neurosciences Inc.
11.11.23
11.11.24
27.08.24
Minerva Neurosciences Inc.
28.05.23
28.05.24
29.05.24
Minerva Neurosciences Inc.
20.05.23
20.05.24
21.05.24
Minerva Neurosciences Inc.
02.04.23
02.04.24
03.04.24
Minerva Neurosciences Inc.
25.03.23
25.03.24
26.03.24
Minerva Neurosciences Inc.
28.02.23
28.02.24
29.02.24